1. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
2. Pediatric Formulations
3. The plight of paediatric drug therapy;Macleod;Paediatr Child Health,2011
4. US Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). Guidance for industry. Guidance for industry. Bioavailability and bioequivalence studies submitted in NDAs or INDs-general considerations. US Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). March 2014. Biopharmaceutics. Available at: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm389370.pdf (accessed November the 11th, 2015).